USPTO serial 79362259
XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 26, 2024
- Examiner
- OAKES, JEFFREY ALLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Vetter Pharma-Fertigung GmbH & Co. KG
DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
DE
DE
DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 039 | Bottling services and storage of goods in the nature of liquid and solid substances, especially, pharmaceuticals, medicines and solutions, for others | ACTIVE | — |
| 040 | Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for others, custom manufacture and assembly services, custom assembly for others of electronic components for medical devices and apparatus, semiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic components, semi-conductor components and circuits for medical apparatus and equipment | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research services, namely, chemical, biochemical, biological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemistry services, namely, chemistry consultation, research in the fields of chemistry; biochemical services, namely, biochemistry consultation, research in the fields of biochemistry; services of medical, bacteriological and chemical laboratories, namely, laboratory research and laboratory analysis; research on the subject of pharmaceuticals; biochemistry research services; development of pharmaceutical, veterinary and diagnostic products and substances and methods for the manufacture thereof, in particular using biotechnological and genetically-engineered means, in the nature of research in the field of manufacturing machinery for pharmaceutical, veterinary and diagnostic products and substances, design and development of computer hardware for the pharmaceutical, veterinary and diagnostic products and substances manufacturing industries; technological consultancy relating to pharmacy, namely, consulting services in the field of pharmaceutical research and development, technical consulting in the field of pharmaceutical studies; technological consultancy in the veterinary research field; technological consultancy in the field of diagnostics, namely, consulting services in the field of pharmaceutical research and development, consulting services in the field of pharmacogenetics; quality control for others; providing information and data relating to medical research and development; development of syringes and instruments for injections, injectors and packaging for the aforesaid goods for others; product quality and product safety testing, namely, chemical testing, physical testing and process engineering testing, in particular laboratory testing; pharmacological and microbiological development, research and analysis for others; conducting clinical tests, namely, scientific research in the nature of conducting clinical trials for others; conducting technical project studies in the nature of scientific feasibility studies and technological support services being technological research in the field of pharmaceutical agent manufacturing processes and pharmaceutical co-filling and packaging processes; industrial manufacturing process development consultancy | ACTIVE | — |
| 044 | Medical services; medical assistance; animal healthcare services, namely, animal breeding, animal grooming, medical analysis services for diagnostic and treatment purposes; consultancy and information services relating to biopharmaceutical products, namely, providing medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Rentschler Biopharma SE
- Other trademarks owned by Rentschler Biopharma SE
- Other trademarks owned by Rentschler Biopharma SE
- Other trademarks in Class 039
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 23, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 8, 2024 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Oct 8, 2024 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 27, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 8, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 20, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 20, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 20, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 5, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 5, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 5, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 9, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 12, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 22, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 14, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 10, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |